CRODA INTL PLC/ADR (OTCMKTS:COIHY) Cut to Equal Weight at Barclays

CRODA INTL PLC/ADR (OTCMKTS:COIHY) was downgraded by equities researchers at Barclays from an “overweight” rating to an “equal weight” rating in a research report issued to clients and investors on Monday, The Fly reports.

A number of other equities analysts have also commented on the company. Zacks Investment Research lowered CRODA INTL PLC/ADR from a “hold” rating to a “sell” rating in a research note on Monday, December 2nd. Goldman Sachs Group lowered CRODA INTL PLC/ADR from a “neutral” rating to a “sell” rating in a research note on Monday, August 12th.

OTCMKTS COIHY opened at $32.96 on Monday. CRODA INTL PLC/ADR has a fifty-two week low of $27.68 and a fifty-two week high of $50.00. The stock’s 50-day moving average is $31.61 and its two-hundred day moving average is $30.90. The company has a debt-to-equity ratio of 0.65, a current ratio of 12.33 and a quick ratio of 6.59. The firm has a market cap of $8.47 billion, a P/E ratio of 25.55, a price-to-earnings-growth ratio of 2.32 and a beta of 0.65.

CRODA INTL PLC/ADR Company Profile

Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company operates in four segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. It offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries.

Featured Article: Stochastic Momentum Index (SMI)

The Fly

Receive News & Ratings for CRODA INTL PLC/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRODA INTL PLC/ADR and related companies with MarketBeat.com's FREE daily email newsletter.